Open AccessOutcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients
Author(s) -
Supreet Sethi,
Reiad Najjar,
Alice Peng,
Jua Choi,
Kathlyn Lim,
Ashley Vo,
Stanley C. Jordan,
Edmund Huang
Publication year - 2019
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000002976
Subject(s) - belatacept , calcineurin , urology , renal function , immunosuppression , medicine , kidney transplantation , kidney transplant , kidney , gastroenterology , transplantation
The efficacy and safety of belatacept when converted from calcineurin inhibitors (CNI) in HLA-sensitized (HS) kidney transplant recipients has not been established.